相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of anti-rVEGF on the expression of VEGF receptor-2 and P2X2/3 receptors of the spinal dorsal horn in neuropathic pain rats
Xin Li et al.
BRAIN RESEARCH BULLETIN (2012)
Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
Astrid A. M. Van der Veldt et al.
CANCER CELL (2012)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors
M. H. G. Langenberg et al.
ANNALS OF ONCOLOGY (2011)
Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation?
Alessandra Marrelli et al.
AUTOIMMUNITY REVIEWS (2011)
Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration
F. Fan et al.
BRITISH JOURNAL OF CANCER (2011)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente et al.
CELL (2011)
Phosphorylation mechanism and structure of serine-arginine protein kinases
Gourisankar Ghosh et al.
FEBS JOURNAL (2011)
Serine-arginine protein kinases: a small protein kinase family with a large cellular presence
Thomas Giannakouros et al.
FEBS JOURNAL (2011)
Molecular characterization and expression patterns of serine/arginine-rich specific kinase 3 (SPRK3) in porcine skeletal muscle
Yongjie Xu et al.
MOLECULAR BIOLOGY REPORTS (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Inhibition of Hepatitis C Virus Replication by a Specific Inhibitor of Serine-Arginine-Rich Protein Kinase
Yuko Karakama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells
Ioannis Sanidas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons
Jiari Lin et al.
BRAIN RESEARCH BULLETIN (2010)
A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins)
James L. Manley et al.
GENES & DEVELOPMENT (2010)
Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
Dawid G. Nowak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vascular Endothelial Growth Factor and Spinal Cord Injury Pain
Olivera Nesic et al.
JOURNAL OF NEUROTRAUMA (2010)
Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
Yan Qiu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
Shenhong Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
G. Merdzhanova et al.
ONCOGENE (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
The anti-angiogenic isoforms of VEGF in health and disease
Yan Qiu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Regulation of Vertebrate Nervous System Alternative Splicing and Development by an SR-Related Protein
John A. Calarco et al.
CELL (2009)
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
Dawid G. Nowak et al.
JOURNAL OF CELL SCIENCE (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGF(xxx)b in Human Kidney Development
Heather S. Bevan et al.
NEPHRON PHYSIOLOGY (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study
Robert A. Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions
Enqi Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Takeshi Fukuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2
O Nakagawa et al.
GENES & DEVELOPMENT (2005)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
BF Schrijvers et al.
KIDNEY INTERNATIONAL (2004)
Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque
FL Celletti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor
M Sondell et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
